Expressions of multidrug resistance markers P-gp,MRP,LRP in lung cancer tissues
Lei Song
Abstract
Lei Song
Abstract
OBJECTIVE:To investigate the expression levels and clinical significance of multidrug resistance(MDR)markers(P-gp,LRP and MRP)in lung cancer tissues.METHODS:The expressions of lung cancer resistance protein(LRP),multidrug resistance protein(MRP)and P-glycoprotein(P-gp)of MDR markers were detected in 116 cases of lung cancer tissues by the streptavidin-biotin-peroxidase(SP)immunohistochemistry technique.RESULTS:There was an overexpression of P-gp in different types of lung cancer tissues and the expression of adenocarcinoma(78.26%),small cell carcinoma(63.64%)and squamous cell carcinoma(47.46%)were significantly different,P=0.018.The expression of LRP in adenocarcinoma(89.13%)was higher than that in squamous carcinoma(44.07%)and that in small cell carcinoma of lung(27.27%),P=0.000 1.No significant difference was observed in the expression of MRP among the different types of lung cancer,P=0.416 5.The expression rates of two kinds or more of MDR markers in the adenocarcinoma,squamous carcinoma and small cell carcinoma were 89.13%,49.15% and 27.28% respectively,P=0.000 1.CONCLUSIONS:There are different degrees of overexpressions of multidrug resistant markers in the different types of lung cancer.Combined detection of P-gp,LRP and MRP may be useful for guiding the clinical chemotherapy of lung cancer.
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
OBJECTIVE:To investigate the expression levels and clinical significance of multidrug resistance(MDR)markers(P-gp,LRP and MRP)in lung cancer tissues.METHODS:The expressions of lung cancer resistance protein(LRP),multidrug resistance protein(MRP)and P-glycoprotein(P-gp)of MDR markers were detected in 116 cases of lung cancer tissues by the streptavidin-biotin-peroxidase(SP)immunohistochemistry technique.RESULTS:There was an overexpression of P-gp in different types of lung cancer tissues and the expression of adenocarcinoma(78.26%),small cell carcinoma(63.64%)and squamous cell carcinoma(47.46%)were significantly different,P=0.018.The expression of LRP in adenocarcinoma(89.13%)was higher than that in squamous carcinoma(44.07%)and that in small cell carcinoma of lung(27.27%),P=0.000 1.No significant difference was observed in the expression of MRP among the different types of lung cancer,P=0.416 5.The expression rates of two kinds or more of MDR markers in the adenocarcinoma,squamous carcinoma and small cell carcinoma were 89.13%,49.15% and 27.28% respectively,P=0.000 1.CONCLUSIONS:There are different degrees of overexpressions of multidrug resistant markers in the different types of lung cancer.Combined detection of P-gp,LRP and MRP may be useful for guiding the clinical chemotherapy of lung cancer.
Key concepts: Lung cancer, Adenocarcinoma, Multiple drug resistance, Immunohistochemistry, Carcinoma, Squamous carcinoma, Cancer, Small-cell carcinoma